tiprankstipranks
Accelerate Diagnostics (AXDX)
NASDAQ:AXDX

Accelerate Diagnostics (AXDX) Financial Statements

287 Followers

Accelerate Diagnostics Financial Overview

Accelerate Diagnostics's market cap is currently ―. The company's EPS TTM is $-5.511; its P/E ratio is -0.16; Accelerate Diagnostics is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.54. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 3.03M$ 3.30M$ 2.92M$ 2.81M$ 2.97M
Gross Profit$ 633.00K$ 107.00K$ 799.00K$ 1.01M$ 651.00K
EBIT$ -13.86M$ 1.04M$ -32.58M$ -15.37M$ -13.42M
EBITDA$ -13.04M$ 1.86M$ -32.52M$ -13.81M$ -11.98M
Net Income Common Stockholders$ -34.45M$ 7.08M$ -32.73M$ -16.80M$ -14.80M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 13.22M$ 21.15M$ 29.28M$ 29.41M$ 34.91M
Total Assets$ 31.37M$ 39.32M$ 49.88M$ 51.00M$ 65.02M
Total Debt$ 39.22M$ 36.57M$ 36.57M$ 60.60M$ 60.68M
Net Debt$ 26.00M$ 15.42M$ 7.29M$ 31.20M$ 25.78M
Total Liabilities$ 51.25M$ 74.36M$ 88.54M$ 89.73M$ 87.28M
Stockholders Equity$ -19.89M$ -35.03M$ -38.66M$ -38.73M$ -22.26M
Cash Flow-
Free Cash Flow$ -7.87M$ 7.70M$ -10.97M$ -13.38M$ -9.66M
Operating Cash Flow$ -7.75M$ 8.46M$ -10.82M$ -13.37M$ -9.56M
Investing Cash Flow$ -110.00K$ -354.00K$ 915.00K$ 8.21M$ 5.84M
Financing Cash Flow$ 107.00K$ 3.18M$ 9.81M$ -77.00K$ -126.00K
Currency in USD

Accelerate Diagnostics Earnings and Revenue History

Accelerate Diagnostics Debt to Assets

Accelerate Diagnostics Cash Flow

Accelerate Diagnostics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis